After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, addresses how tariffs will affect pharmaceutical costs and which drug categories will be most affected.

Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for ...

Pfizer made changes to its DEI webpage, joining other companies across different industries repositioning their messaging ...

The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a ...

Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official ...

For Zevra Therapeutics, last year’s approval of the rare lysosomal storage disorder drug Miplyffa appears to be the gift that ...